Search for Novartis AG and
    1. Fast FT

      April 28, 2016

      Norway's sovereign wealth fund hit by global stock turmoil

      Norway’s $870bn oil fund recorded its third quarter of negative returns in the past year as weak stock markets from...

    2. Fast FT

      April 27, 2016

      GlaxoSmithKline Q1 growth aided by HIV drugs

      Sir Andrew Witty began his final year in charge of GlaxoSmithKline with a stronger-than-expected rise in first quarter...

    Special Reports

    1. Combating Malaria

      Malaria kills more than 400,000 people a year, most of them children in Africa. New we...
    2. Innovative Lawyers

      Since 2006 this report has weighed and ranked a profession in a period of transformati...
    Search more Special Reports on this topic.

    1. April 24, 2016

      Big Pharma hunts for malaria drugs to fight mosquito resistance

      China’s first Nobel Prize for physiology or medicine was 419 years in the making. Tu Youyou, an 85 year-old chemist,...

    2. April 21, 2016

      Novartis chief warns of paradigm shift to slower US drug sales

      Pharmaceuticals companies can no longer count on rapid uptake of new drugs in the US, the chief executive of Novartis...

    3. Fast FT

      April 21, 2016

      Novartis profits drop in Q1

      Falling sales and slow sales of a vaunted new heart drug – it was much the same story for Novartis in the first months...

    4. Fast FT

      April 21, 2016

      Fast Europe Open: Turkish tensions

      Tensions are growing over a promise to grant visa-free travel for 80m Turks to Europe’s Schengen area. A month-old...

    5. April 18, 2016

      Clouds gather over Novartis as it battles series of setbacks

      Joe Jimenez is facing a battle to restore investor confidence in Novartis after a series of setbacks which have sent...

    6. April 3, 2016

      GSK returns to battle against cancer

      When GlaxoSmithKline agreed to sell its oncology drugs to Novartis for $16bn in 2014, it looked like the UK...

    7. Fast FT

      March 10, 2016

      Sanofi plucks new chief medical officer from Novartis

      French drugmaker Sanofi has plucked a new senior executive from rival Swiss healthcare group Novartis. Dr Ameet...

    8. Fast FT

      March 2, 2016

      ISS raises dividend 51%

      ISS, the Danish cleaning and catering group, more than doubled profits last year allowing it to significantly raise its...

    9. February 23, 2016

      Health spending cannot be set by fans of Facebook and Instagram

      To have the option of saving a child’s life and to reject it seems more than callous. It is the ugliest of affronts to...

    10. February 4, 2016

      Activist investors: hard drugs

      Failed in New Jersey? Try Basel. Investors in Johnson & Johnson have tried to gin up interest among activists in...

    11. February 3, 2016

      GSK’s Witty avoids the City’s would-be surgeons

      Sir Andrew Witty, chief executive of GlaxoSmithKline, is having his yearly City health check up. Corporate doctor: What...

    12. February 1, 2016

      Investor calls for big pharma to slim down grow louder

      Some of the world’s biggest pharmaceuticals groups are facing calls to break up their diversified businesses in favour...

    13. January 27, 2016

      Novartis revamps Alcon eyecare division

      Novartis has set a deadline for its struggling eyecare business to return to growth by the end of this year or risk...

    14. Fast FT

      January 27, 2016

      Novartis to streamline operations, misses estimates

      Novartis has announced plans to streamline its operations as a strong US dollar continued to weigh on its earnings. The...

    15. January 21, 2016

      Drugmakers call for collective action on superbugs

      Most of the world’s biggest pharmaceuticals groups have backed a declaration committing the industry to help tackle...

    16. January 20, 2016

      GlaxoSmithKline and Qualcomm in talks over health tech tie-up

      GlaxoSmithKline and Qualcomm are in talks to set up a joint venture potentially worth up to $1bn to develop medical...

    17. January 11, 2016

      Investors warm to UK science parks

      The UK’s largest portfolio of privately owned science parks has been bought by a US private equity company in a deal...

    18. January 3, 2016

      GSK and AstraZeneca prescribe different treatments

      For GlaxoSmithKline and AstraZeneca — twin pillars of Britain’s pharmaceuticals sector — 2016 promises to be a critical...

    19. December 15, 2015

      Sanofi/Boehringer: swap shop

      Swapping assets was a form of human trade since long before bankers and their fees arrived on the scene. In...

    20. December 15, 2015

      Sanofi seeks to expand in consumer health with €18bn asset swap

      Sanofi has entered exclusive talks with Boehringer Ingelheim over an €18bn asset exchange that would see the French...

    21. December 15, 2015

      FDA performs U-turn over restriction of pain drug

      US regulators have taken the rare step of reversing a decision aimed at curbing the use of a pain medicine after the...

    22. December 7, 2015

      Race to control costs of cancer therapy revolution

      It is three and a half years since Emily Whitehead from Pennsylvania was given an experimental treatment for her acute...

    23. December 6, 2015

      China healthcare: Missing a beat

      Not long after taking the helm of GlaxoSmithKline in 2008, Sir Andrew Witty visited Shanghai to deliver a message along...

    24. November 26, 2015

      Unhealthy drugs: Pharma struggles with its reputation

      An industry dedicated to saving and extending lives might be expected to find empathy easy. Instead, some of the...

    25. November 17, 2015

      GSK and the perils of prudence

      Since the low point of the financial crisis almost seven years ago, stock markets have sent a clear message: do not...

    26. November 13, 2015

      Animal health: double or quits

      Sea lice. Fowl pox. Swine fever. Foot-and-mouth. Animal diseases often take prosaic names. This does not make them...

    27. November 3, 2015

      GSK unveils new drugs to boost growth

      GlaxoSmithKline has revealed details of dozens of new drugs that it says will help drive recovery in the UK...

    28. November 3, 2015

      Blood cell therapy puts Wallonia ahead in biotech race

      A technology called Car-T therapy — which involves re-engineering a patient’s disease-fighting white blood cells so...

    29. November 2, 2015

      Pfizer spurned by GSK before Allergan talks

      Pfizer approached GlaxoSmithKline about a possible takeover in recent weeks but was rebuffed before confirming its...

    30. October 27, 2015

      Novartis to pay $390m to settle kickback claims

      Novartis will pay $390m to settle US allegations that it used kickbacks to specialist pharmacies to push sales of some...

    31. October 6, 2015

      Bristol-Myers to pay SEC $14m to settle China bribery claim

      US drugmaker Bristol-Myers Squibb is to pay $14m in penalties to US authorities over alleged “improper payments” made...

    32. October 2, 2015

      Law firms implement tactics to level the playing field

      In March, GlaxoSmithKline and Novartis completed a landmark $23bn asset swap that was widely hailed as a template for...

    33. September 24, 2015

      Pharmaceuticals: Value over volume

      It was probably the most expensive tweet in history. A 21-word missive from Hillary Clinton on Monday wiped more than...

    34. September 15, 2015

      Philips to spin off lighting arm and step up medical tech drive

      From the earliest lightbulbs and transistor radios to the first flatscreen televisions, Philips was Europe’s...

    35. September 3, 2015

      Novartis launches first biological copycat drug in US

      Novartis has launched the first cut-price copy of an expensive biological drug in the US, opening the way for a new...

    36. FT Alphaville

      August 21, 2015

      Opening Quote: Beware China's bemused markets

      You can sign up for the full, pre-market email briefing here Art provocateur Banksy is opening a “bemusement park”...

    37. August 10, 2015

      Australia’s CSL warns of biotech bubble

      CSL, the Australian company that recently bought Novartis’s influenza business, has warned of a “biotech bubble” amid a...

    38. July 29, 2015

      HIV/Aids treatments stand out as GSK promises 40-drug pipeline

      GlaxoSmithKline flagged a pipeline of 40 new drugs in advanced clinical trials as it beat market forecasts for the...

    Search for Novartis AG and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Novartis CEO on new growth opportunities...
      July 26, 2015

      Novartis CEO on new growth opportunities

    2. Lex on potential conflict at Swiss drugs group...
      July 17, 2013

      Lex on potential conflict at Swiss drugs group

    3. Lex on Novartis' payment to its outgoing chairman...
      February 18, 2013

      Lex on Novartis' payment to its outgoing chairman